Document is current

Article History

Received: 23 October 2017

Accepted: 21 December 2017

First Online: 12 January 2018

Ethics approval and consent to participate

: Subjects in this study were part of PREDICT, a multi-center US study of patients referred for coronary angiography (ExternalRef removed, NCT00500617). The institutional review boards at all centers approved the study (Duke University School of Medicine, Durham, North Carolina; Minneapolis Heart Institute and Foundation, Minneapolis, Minnesota; Piedmont Heart Institute, Atlanta, Georgia; Cleveland Clinic Foundation, Cleveland, Ohio; Oklahoma Cardiovascular Research Group, Oklahoma City, Oklahoma; Cardiovascular Research Institute, Medstar Research Institute, Washington, DC; Vanderbilt Heart and Vascular Institute, Nashville, Tennessee; Cardiovascular Research Foundation, New York, New York; and Scripps Translational Science Institute, La Jolla, California), and all patients gave written informed consent. Specific IRB protocol numbers can be found in Additional file InternalRef removed: Table S3.

: Not applicable.

: JAW, BR, and KF are/were full-time employees of and hold stock in CardioDx. SR reported serving as a consultant and advisory board member for CardioDx and holding stock and stock options in CardioDx.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.